Search

everythinglearnresearchcommunity

for

Search:↓

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Type 2 inflammation helps wound healing by switching immune cells to repair mode.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

LTBP1 is a key regulator in diseases and a potential target for new treatments.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

RTA 408 cream protects mice from radiation skin damage.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Lhx2 helps retinal cells respond to signals for eye development.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Inflammasome proteins can predict inflammation and outcomes in aneurysmal subarachnoid hemorrhage.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.